• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude+Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

BioLargo Engineering Secures Multi-Year Air Force Base Air Compliance Project

By: ACCESSWIRE
June 07, 2024 at 07:55 AM EDT
ⓘ This article is third-party content and does not represent the views of this site. We make no guarantees regarding its accuracy or completeness.

WESTMINSTER, CA / ACCESSWIRE / June 7, 2024 / BioLargo, Inc. (OTCQX:BLGO), a company that creates and commercializes sustainable technologies to solve tough environmental and cleantech challenges, announced that its engineering subsidiary has been awarded a contract to provide air quality services to three New Mexico U.S. Air Force (USAF) bases for up to five years, with a potential annual average revenue of $650,000.

The new contract is in addition to ongoing environmental support work at six Air Force bases and is the company's largest dollar-value Air Force contract to date. These contracts provide regularly monthly flat fee revenue to the company over the life of the contract, which the Air Force may renew each year. BioLargo's work at the New Mexico bases includes air quality regulatory compliance. Bhate Environmental Associates is the prime contractor with the Air Force under the Fence-to-Fence (F2F) support contract.

BioLargo Engineering, Science & Technologies President Randall Moore commented, "Our team has served Air Force bases with fence-to-fence air quality compliance services for years, but this is the largest such contract we've secured to-date. Larger, long-term contracts such as this one are crucial to our strategy of securing steady, reliable income from external clients. This empowers us to focus on commercializing BioLargo's innovative cleantech technologies, including advancements in water treatment, energy storage, and air quality solutions."

About BioLargo, Inc.

BioLargo, Inc. (OTCQB:BLGO) is a cleantech and life sciences innovator and engineering services solution provider. Our core products address PFAS contamination, achieve advanced water and wastewater treatment, control odor and VOCs, improve air quality, enable energy-efficiency and safe on-site energy storage, and control infections and infectious disease. Our approach is to invent or acquire novel technologies, develop them into product offerings, and extend their commercial reach through licensing and channel partnerships to maximize their impact. See our website at www.BioLargo.com.

About Bhate Environmental Associates, Inc.

Bhate Environmental Associates, Inc. (Bhate) provides a diverse range of technical services in the environmental and infrastructure markets to the federal government and private industry. Headquartered in Birmingham, Alabama, Bhate's reach is both national and global. At Bhate, we value high standards of safety, professionalism, ethics, and service to our clients. We foster a collaborative environment that encourages innovative ideas while providing challenges and rewards for our dedicated staff. Through our team's Responsiveness, Integrity, and Teamwork, Bhate delivers professional, quality, cost-effective, and on-time results to our clients. See their website at www.Bhate.com.

Contact Information

Dennis P. Calvert
President and CEO, BioLargo, Inc.
888-400-2863

Safe Harbor Act

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements include without limitation those about BioLargo's (the "Company") expectations regarding anticipated revenue; and plans for future operations. These statements involve risks and uncertainties, and actual results may differ materially from any future results expressed or implied by the forward-looking statements. Risks and uncertainties include without limitation: the effect of regional economic conditions on the Company's business, including effects on purchasing decisions by consumers and businesses; the ability of the Company to compete in markets that are highly competitive and subject to rapid technological change; the ability of the Company to manage frequent introductions and transitions of products and services, including delivering to the marketplace, and stimulating customer demand for, new products, services, and technological innovations on a timely basis; the dependency of the Company on the performance of distributors of the Company's products. More information on these risks and other potential factors that could affect the Company's business and financial results is included in the Company's filings with the SEC, including in the "Risk Factors" and "Management's Discussion and Analysis of Financial Condition and Results of Operations" sections of the Company's most recently filed periodic reports on Form 10-K and Form 10-Q and subsequent filings. The Company assumes no obligation to update any forward-looking statements or information, which speak as of their respective dates.

SOURCE: BioLargo, Inc.



View the original press release on accesswire.com

Report this content

If you believe this article contains misleading, harmful, or spam content, please let us know.

Report this article

More News

View More
News headline image
Biogen Stock Slides After Trial Miss, But Analysts Stay Bullish ↗
Today 7:50 EDT
Via MarketBeat
Tickers APLS BIIB
News headline image
Intuit's Great SaaS Reset: Fired By AI ↗
Today 7:10 EDT
Via MarketBeat
Topics Artificial Intelligence
Tickers INTU
News headline image
CorMedix Eyes REZZAYO Expansion as DefenCath Reimbursement Shift Looms ↗
Today 6:04 EDT
Via MarketBeat
Tickers CRMD
News headline image
Helical H2 Earnings Call Highlights ↗
Today 6:04 EDT
Via MarketBeat
Topics Earnings
News headline image
Corbus Pharmaceuticals Teases Key ASCO Cancer Data, Late-Summer Obesity Readout ↗
Today 3:04 EDT
Via MarketBeat
Tickers CRBP RY TSX:RY

Recent Quotes

View More
Symbol Price Change (%)
AMZN  268.46
+0.00 (0.00%)
AAPL  304.99
+0.00 (0.00%)
AMD  449.59
+0.00 (0.00%)
BAC  51.49
+0.00 (0.00%)
GOOG  383.47
+0.00 (0.00%)
META  607.38
+0.00 (0.00%)
MSFT  419.09
+0.00 (0.00%)
NVDA  219.51
+0.00 (0.00%)
ORCL  189.77
+0.00 (0.00%)
TSLA  417.85
+0.00 (0.00%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap